Next 10 |
2025-02-12 20:40:00 ET Summary The Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Stock selection in healthcare equipment contributed to relative returns, while positioning in pharmaceuticals weighed on performance. Near-term policy uncertainty ...
2025-02-12 16:26:06 ET Summary The Voya Global Advantage and Premium Opportunity Fund offers a high 10.74% yield, outperforming major domestic equity and fixed-income indices, making it attractive for income-focused investors. Despite its high yield, the IGA closed-end fund's five...
2025-02-12 15:52:29 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the financial landscape. ...
2025-02-12 12:09:03 ET More on markets Treasury yields rocket higher after inflation data rises more than expected ‘We think the Mag7 are vulnerable’ - Cantor Fitzgerald VanEck spotlights 10 robotics companies that are driving the future Trump's...
2025-02-12 10:26:58 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the financial landscape. ...
2025-02-12 09:04:41 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the biotech industry’s finan...
2025-02-12 08:40:06 ET More on AbbVie, Xilio Therapeutics, etc. AbbVie Q4 Earnings: Strong Revenue Results, Ambitious Forecasts - A Buy With Caveats AbbVie Q4 Earnings: Good 2025 Outlook Despite Enhanced Old And New Headwinds AbbVie Inc. (ABBV) Q4 2024 Earnings Call ...
2025-02-11 23:39:00 ET Summary Underperformance mainly resulted from stock selection in health care and communication services. An underweight in consumer discretionary also detracted. This was partially offset by stronger stock selection in financials, information technology and mate...
2025-02-11 17:20:43 ET Summary Axsome Therapeutics, Inc.'s stock has surged over 30% since my last “Hold” rating, driven by key catalysts like the litigation settlement with Teva Pharmaceuticals, announced today. Axsome's Auvelity and Sunosi are crucial, with Auvelit...
2025-02-08 14:25:24 ET More on Health Care Select Sector SPDR® Fund ETF XLV: With Relative Strength In January And Compelling Valuation, Health Care Earnings On Tap XLV: Buy Diversity And Growth XLV: Healthcare Stocks In Critical Condition (Rating Downgrade) ...
News, Short Squeeze, Breakout and More Instantly...
2025-02-12 15:52:29 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the financial landscape. ...
2025-02-12 10:26:58 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the financial landscape. ...
2025-02-12 09:04:41 ET DENVER, Colo., Feb 12, 2025 ( 247marketnews.com )- 24/7 Market News, a trusted source for real-time financial news and market analysis, highlights today’s most significant stock movements and breaking developments shaping the biotech industry’s finan...